Literature DB >> 24566993

From pericytes to perivascular tumours: correlation between pathology, stem cell biology, and tissue engineering.

Marco Mravic1, Greg Asatrian, Chia Soo, Claire Lugassy, Raymond L Barnhill, Sarah M Dry, Bruno Peault, Aaron W James.   

Abstract

PURPOSE: Pericytes were once thought only to aid in angiogenesis and blood pressure control. Gradually, the known functions of pericytes and other perivascular stem cells (PSC) have broadly increased. The following review article will summarize the known functions and importance of pericytes across disciplines of pathology, stem cell biology, and tissue engineering.
METHODS: A literature review was performed for studies examining the importance of pericytes in pathology, stem cell biology, and tissue engineering.
RESULTS: The importance of pericytes most prominently includes the identification of the perivascular identity of mesenchymal stem cells (or MSC). Now, pericytes and other PSC are known to display surface markers and multilineage differentiation potential of MSC. Accordingly, interest in the purification and use of PSC for mesenchymal tissue formation and regeneration has increased. Significant demonstration of in vivo efficacy in bone and muscle regeneration has been made in laboratory animals. Contemporaneously with the uncovering of an MSC identity for pericytes, investigators in tumour biology have found biologically relevant roles for pericytes in tumor formation, lymphovascular invasion, and perivascular tumor spread. As well, the contribution of pericytes to perivascular tumors has been examined (and debated), including glomus tumour, myopericytoma and solitary fibrous tumour/hemangiopericytoma. In addition, an expanding recognition of pericyte mimicry and perivascular tumour invasion has occurred, encompassing common malignancies of the brain and skin.
CONCLUSIONS: In summary, pericytes have a wide range of roles in health and disease. Pericytes are being increasingly studied for their role in tumour formation, growth and invasion. Likewise, the application of pericytes/PSC for mesenchymal tissue engineering is an expanding field of interest.

Entities:  

Mesh:

Year:  2014        PMID: 24566993     DOI: 10.1007/s00264-014-2295-0

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  37 in total

Review 1.  Gene expression during vascular pericyte differentiation.

Authors:  M J Doherty; A E Canfield
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1999       Impact factor: 1.807

2.  Chondrogenic and adipogenic potential of microvascular pericytes.

Authors:  C Farrington-Rock; N J Crofts; M J Doherty; B A Ashton; C Griffin-Jones; A E Canfield
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

3.  Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation.

Authors:  S R Granter; K Badizadegan; C D Fletcher
Journal:  Am J Surg Pathol       Date:  1998-05       Impact factor: 6.394

4.  Lipomatous hemangiopericytoma: a morphologically distinct soft tissue tumor.

Authors:  K M Ceballos; P L Munk; B A Masri; J X O'Connell
Journal:  Arch Pathol Lab Med       Date:  1999-10       Impact factor: 5.534

Review 5.  Familial generalized multiple glomangiomyoma: report of a new family, with immunohistochemical and ultrastructural studies and review of the literature.

Authors:  Luis Calduch; Carlos Monteagudo; Esperanza Martínez-Ruiz; Dolores Ramón; Isabel Pinazo; Carmen Cardá; Esperanza Jordá
Journal:  Pediatr Dermatol       Date:  2002 Sep-Oct       Impact factor: 1.588

6.  Analysis of mural cell recruitment to tumor vessels.

Authors:  Alexandra Abramsson; Orjan Berlin; Hayk Papayan; Denise Paulin; Moshe Shani; Christer Betsholtz
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

7.  Lipomatous hemangiopericytoma. A histologic, ultrastructural and immunohistochemical study of a unique variant of hemangiopericytoma.

Authors:  G P Nielsen; G R Dickersin; J M Provenzal; A E Rosenberg
Journal:  Am J Surg Pathol       Date:  1995-07       Impact factor: 6.394

8.  Pilot study on "pericytic mimicry" and potential embryonic/stem cell properties of angiotropic melanoma cells interacting with the abluminal vascular surface.

Authors:  Claire Lugassy; Madhuri Wadehra; Xinmin Li; Mirko Corselli; David Akhavan; Scott W Binder; Bruno Péault; Alistair J Cochran; Paul S Mischel; Hynda K Kleinman; Raymond L Barnhill
Journal:  Cancer Microenviron       Date:  2012-12-29

9.  Could pericytic mimicry represent another type of melanoma cell plasticity with embryonic properties?

Authors:  Claire Lugassy; Bruno Péault; Madhuri Wadehra; Hynda K Kleinman; Raymond L Barnhill
Journal:  Pigment Cell Melanoma Res       Date:  2013-06-27       Impact factor: 4.693

Review 10.  Perivascular cells for regenerative medicine.

Authors:  Mihaela Crisan; Mirko Corselli; William C W Chen; Bruno Péault
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

View more
  15 in total

1.  Comparative analysis of rat mesenchymal stem cells derived from slow and fast skeletal muscle in vitro.

Authors:  Etsuko Okumachi; Sang Yang Lee; Takahiro Niikura; Takashi Iwakura; Yoshihiro Dogaki; Takahiro Waki; Shunsuke Takahara; Takeshi Ueha; Yoshitada Sakai; Ryosuke Kuroda; Masahiro Kurosaka
Journal:  Int Orthop       Date:  2014-10-23       Impact factor: 3.075

Review 2.  Cellular Based Strategies for Microvascular Engineering.

Authors:  Srinivas V Koduru; Ashley N Leberfinger; Denis Pasic; Anoosha Forghani; Shane Lince; Daniel J Hayes; Ibrahim T Ozbolat; Dino J Ravnic
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

3.  Comparison of skeletal and soft tissue pericytes identifies CXCR4+ bone forming mural cells in human tissues.

Authors:  Jiajia Xu; Dongqing Li; Ching-Yun Hsu; Ye Tian; Leititia Zhang; Yiyun Wang; Robert J Tower; Leslie Chang; Carolyn A Meyers; Yongxing Gao; Kristen Broderick; Carol Morris; Jody E Hooper; Sridhar Nimmagadda; Bruno Péault; Aaron W James
Journal:  Bone Res       Date:  2020-05-22       Impact factor: 13.567

4.  Tissue engineering and regenerative orthopaedics (TERO).

Authors:  Marko Pećina; Slobodan Vukičević
Journal:  Int Orthop       Date:  2014-08-12       Impact factor: 3.075

5.  Pericytoma With t(7;12) and ACTB-GLI1 Fusion: Reevaluation of an Unusual Entity and its Relationship to the Spectrum of GLI1 Fusion-related Neoplasms.

Authors:  Darcy A Kerr; Andre Pinto; Ty K Subhawong; Breelyn A Wilky; Matthew P Schlumbrecht; Cristina R Antonescu; G Petur Nielsen; Andrew E Rosenberg
Journal:  Am J Surg Pathol       Date:  2019-12       Impact factor: 6.394

6.  Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition.

Authors:  F Böhrnsen; M Fricke; C Sander; A Leha; H Schliephake; F J Kramer
Journal:  Clin Oral Investig       Date:  2014-10-28       Impact factor: 3.573

Review 7.  Pericytes for Therapeutic Bone Repair.

Authors:  Carolyn A Meyers; Joan Casamitjana; Leslie Chang; Lei Zhang; Aaron W James; Bruno Péault
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

8.  The pericyte antigen RGS5 in perivascular soft tissue tumors.

Authors:  Jia Shen; Swati Shrestha; Yu-Hsin Yen; Michelle A Scott; Chia Soo; Kang Ting; Bruno Peault; Sarah M Dry; Aaron W James
Journal:  Hum Pathol       Date:  2015-09-30       Impact factor: 3.466

9.  Pericyte Antigens in Perivascular Soft Tissue Tumors.

Authors:  Jia Shen; Swati Shrestha; Yu-Hsin Yen; Greg Asatrian; Marco Mravic; Chia Soo; Kang Ting; Sarah M Dry; Bruno Peault; Aaron W James
Journal:  Int J Surg Pathol       Date:  2015-06-17       Impact factor: 1.271

10.  Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination.

Authors:  Claire Lugassy; Sohila Zadran; Laurent A Bentolila; Madhuri Wadehra; Roshini Prakash; S Thomas Carmichael; Hynda K Kleinman; Bruno Péault; Lionel Larue; Raymond L Barnhill
Journal:  Cancer Microenviron       Date:  2014-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.